Comments on: Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries

Comments on: Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries https://anticov.org/press-releases/2022/pfizer-blocking-research-to-generate-evidence-on-optimal-use-of-novel-antiviral-for-covid-19-patients-in-low-and-middle-income-countries/ Platform trial to find early treatment options for COVID-19 in low-resource settings Thu, 17 Mar 2022 10:52:48 +0000 hourly 1 https://wordpress.org/?v=6.7.1